Investors

Prior Events & Presentations

June 25, 2026

“Expanding Non-Opioid Pain Treatment Options in the U.S”

JonesTrading ViFireside Chat with Shawn Fatholahi, President & CEO, MAXONA Pharmaceuticals

https://zoom.us/rec/share/r6FtitxJ_hrG2wkYUKP9MbM3d8CudabniZSTvJemD41jH_G_XF0m8DY1J-fcSkFE.eNlqXdhpgHv9AAM8

This presentation includes forward looking statements.  All statements contained herein other than statements of historical facts are forward-looking statements.  The words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “will”, “completes” and similar expressions are intended to identify forward-looking statements.  These forward-looking statements, including regulatory timelines, are subject to a number of risks, uncertainties and assumptions.  It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially  from those contained  in any  forward-looking statements we may make.  In light of these risks, uncertainties and assumptions, the future events discussed herein may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.  We cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur.  We are under no duty to update any of these forward-looking statements after the date of this presentation to conform these statements to actual results or revised expectations, except as required by law. Nothing in this presentation should be regarded as a representation by any person that these goals will be achieved.

Upcoming Events & Presentations

September 29, 2026

5th Annual Roth Health Care Conference

New York, NY